The potential role of estrogen receptors and the SRC family as targets for the treatment of breast cancer

Type I receptor tyrosine kinases as predictive or prognostic markers in early breast cancer

(2008) M Spears et al.   Biomarkers in Medicine

Tamoxifen Resistance in Breast Tumors Is Driven by Growth Factor Receptor Signaling with Repression of Classic Estrogen Receptor Genomic Function

(2008) S. Massarweh et al.   CANCER RESEARCH

The PTEN/PI3K/AKT Signalling Pathway in Cancer, Therapeutic Implications

(2008) Amancio Carnero et al.   CURRENT CANCER DRUG TARGETS

Estrogen and its receptors in cancer

(2008) George G Chen et al.   MEDICINAL RESEARCH REVIEWS

Estrogen actions on mitochondria—Physiological and pathological implications

(2008) James W. Simpkins et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial

(2007) Birgitte B Rasmussen et al.   LANCET ONCOLOGY